Oura Health IPO Announcement
Oura Health Oy, the Finnish maker of a discreet smart ring that tracks health, fitness, and sleep metrics, is preparing a United States initial public offering that could commence as early as September 2026. The company is targeting a raise of up to $3 billion from the offering, which would place its post‑money valuation at more than $16 billion.
The proposed valuation marks a substantial increase from the $11 billion valuation recorded in September 2025, when Oura completed an $875 million Series E financing round. The company filed a confidential IPO registration in May 2026, and the filing indicates that existing investors intend to sell a portion of their holdings, although the exact size of the secondary sale remains under discussion and the final terms may still be adjusted.
To manage the transaction, Oura has assembled an underwriting syndicate comprising Goldman Sachs Group Inc., Morgan Stanley, JPMorgan Chase & Co., Allen & Co., and Jefferies Financial Group Inc. These banks will lead the book‑building and allocation process for the shares.
The IPO comes at a time when larger technology firms are expanding into the wearable‑ring segment; Samsung Electronics introduced its own smart ring two years ago, and Apple Inc. continues to develop AI‑enabled wearable devices. Oura’s leadership expects that the infusion of fresh capital will strengthen its balance sheet, enabling it to defend its early‑stage market lead against these emerging competitors.